Chu Yu-Waye
- SEC CIK
- 0001854586
In the past year, 1 open-market sale filing worth $136.6K and no purchases.
Current role at each company
- CTMX CytomX Therapeutics, Inc.Chief Medical Officeras of Mar 19, 2026
- FATE Fate Therapeutics IncChief Medical Officeras of Apr 19, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $136.6K
- 1 filing
- Net
- −$136.6K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Chu Yu-Waye as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CTMX CytomX Therapeutics, Inc.
Chief Medical Officer2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 19, 2026 (view filing) | Mar 17 | 2 days | Chu Yu-WayeChief Medical Officer | SSale | −21.3K | $6.42 | −$136.6K | −10.1%189.4K after | |
| Mar 20, 2025 (view filing) | Mar 18 | 2 days | Chu Yu-WayeChief Medical Officer | SSale | −4.03K | $0.60 | −$2.42K | −2.9%135.7K after |
FATE Fate Therapeutics Inc
Chief Medical Officer5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 19, 2023 (view filing) | Apr 18 | 1 day | Chu Yu-WayeChief Medical Officer | SSale | −2.53K | $6.57 | −$16.6K | −1.8%140.7K after | 2 lots10b5-1 |
| Jan 11, 2023 (view filing) | Jan 10 | 1 day | Chu Yu-WayeChief Medical Officer | SSale | −7.83K | $5.24 | −$41.0K | −5.2%143.2K after | |
| Apr 21, 2022 (view filing) | Apr 19 | 2 days | Chu Yu-WayeChief Medical Officer | SSale | −4.06K | $35.37 | −$143.7K | −2.6%151.0K after | |
| Jan 13, 2022 (view filing) | Jan 11 | 2 days | Chu Yu-WayeSenior VP Clinical Development | SSale | −3.96K | $48.51 | −$192.3K | −3.2%121.8K after | 2 lots |
| Dec 13, 2021 (view filing) | Dec 10 | 3 days | Chu Yu-WayeSenior VP Clinical Development | SSale | −7.50K | $51.46 | −$385.9K | −5.6%125.8K after | 7 lots |